The Trans Pacific Partnership Agreement: Implications for public health regulation and access to medicines

Revision as of 01:57, 17 July 2011

PHM Oz is concerned about proposed intellectual property and investment provisions in the Trans Pacific Partnership Agreement (TPPA) that could undermine public health regulation and access to essential medicines.

The TPPA is a regional agreement currently being negotiated between Australia, the US, New Zealand, Chile, Singapore, Brunei, Peru, Vietnam and Malaysia.

Campaign activities

PHM Oz has joined with many other civil society organisations in signing an open letter to Julia Gillard and Craig Emerson protesting the secrecy under which TPPA negotiations are being conducted, and calling for an open and transparent negotiation process.

Read the AFTINET Press Release

PHM Oz has also endorsed an AFTINET sign-on letter to the trade ministers of the TPPA negotiating countries. This letter urges the parties to consider excluding intellectual property and pharmaceuticals provisions from the TPPA, or at least to table alternatives to the TRIPS-plus model.

Further information

Read the AFTINET TPPA Campain Leaflet

Order the book 'No Ordinary Deal: Unmasking the Trans-Pacific Partnership Free Trade Agreement, edited by Jane Kelsey (2010). About the book: At a time when the global financial crisis has exposed deep flaws in the global free market, the US, Australia, New Zealand, Brunei, Chile, Peru and Vietnam are negotiating a free-trade agreement initiated by the US which resurrects the issues raised by the US-Australia Free Trade Agreement in 2004, including higher prices for Australian medicines, less local media content and deregulation of GE food. Jane Kelsey and her international team of expert commentators, including Dr Patricia Ranald, expose the myths of yet another neo-liberal adventure.